Literature DB >> 33377967

The Hidden Epidemic of Opioid Overdoses During the Coronavirus Disease 2019 Pandemic.

Thomas R Kosten1, Ismene L Petrakis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33377967     DOI： 10.1001/jamapsychiatry.2020.4148

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  9 in total

1.  Light at the End of the Pandemic Tunnel?

Authors:  George J Hruza
Journal:  Mo Med       Date:  2021 Jan-Feb

Review 2.  Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.

Authors:  Ying Han; Lu Cao; Kai Yuan; Jie Shi; Wei Yan; Lin Lu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

3.  Preclinical Efficacy and Selectivity of Vaccines Targeting Fentanyl, Alfentanil, Sufentanil, and Acetylfentanyl in Rats.

Authors:  Carly Baehr; Christine Robinson; Andrew Kassick; Rajwana Jahan; Valeria Gradinati; Saadyah E Averick; Scott P Runyon; Marco Pravetoni
Journal:  ACS Omega       Date:  2022-05-04

4.  Big Events theory and measures may help explain emerging long-term effects of current crises.

Authors:  Samuel R Friedman; Pedro Mateu-Gelabert; Georgios K Nikolopoulos; Magdalena Cerdá; Diana Rossi; Ashly E Jordan; Tarlise Townsend; Maria R Khan; David C Perlman
Journal:  Glob Public Health       Date:  2021-04-11

Review 5.  Physical and Psychological Health Behavior Changes During the COVID-19 Pandemic that May Inform Surgical Prehabilitation: a Narrative Review.

Authors:  Julie K Silver; Daniel Santa Mina; Andrew Bates; Chelsia Gillis; Emily M Silver; Tracey L Hunter; Sandy Jack
Journal:  Curr Anesthesiol Rep       Date:  2022-02-18

Review 6.  Friend of the Devil: Negative Social Influences Driving Substance Use Disorders.

Authors:  Matthew B Pomrenze; Franciely Paliarin; Rajani Maiya
Journal:  Front Behav Neurosci       Date:  2022-02-10       Impact factor: 3.558

7.  Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder.

Authors:  Alice Fiddian-Green; Aline Gubrium; Calla Harrington; Elizabeth A Evans
Journal:  Int J Environ Res Public Health       Date:  2022-07-30       Impact factor: 4.614

8.  Has the United States Reached a Plateau in Overdoses Caused by Synthetic Opioids After the Onset of the COVID-19 Pandemic? Examination of Centers for Disease Control and Prevention Data to November 2021.

Authors:  Kate G Brown; Carina Y Chen; Deanna Dong; Kimberly J Lake; Eduardo R Butelman
Journal:  Front Psychiatry       Date:  2022-07-07       Impact factor: 5.435

Review 9.  Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?

Authors:  Cayley Russell; Shannon Lange; Fiona Kouyoumdjian; Amanda Butler; Farihah Ali
Journal:  Harm Reduct J       Date:  2022-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.